Stay updated on Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial

Sign up to get notified when there's something new on the Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.1%
    Check dated 2024-12-15T00:50:34.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with a reference to the Contacts and Locations section.
    Difference
    3%
    Check dated 2024-12-07T22:54:23.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The website has added new features while removing several elements related to study data downloads and participant information.
    Difference
    5%
    Check dated 2024-11-23T06:34:53.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The website has been updated to version v2.12.2, introducing new features for downloading study data in various formats, while the previous version v2.12.1 has been removed.
    Difference
    5%
    Check dated 2024-11-08T19:30:11.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The website has been updated from version 2.12.0 to 2.12.1.
    Difference
    0.1%
    Check dated 2024-11-01T11:51:13.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.
    Difference
    0.2%
    Check dated 2024-10-25T01:33:54.000Z thumbnail image

Stay in the know with updates to Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fruquintinib-Sintilimab Combo in Refractory CRC Clinical Trial page.